MD as reported
Pediatrix Medical Group, Inc. reported $1.95B of revenue over the trailing twelve months, +0.51% on the year before. 10 reported series are charted on this page, each one as filed.
$1.95B
Revenue, trailing twelve months · to Q2 2026 · +0.51% against the twelve months before
- Net Income
- $175M
Net Income · +59% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $229M
Free Cash Flow · +0.72% year on year · trailing twelve months to Q2 2026
- Op Margin
- 11%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $1.95B | +0.51% | Q2 2026 |
| Net Income | $175M | +59% | Q2 2026 |
| EPS | $2.09 | +61% | Q2 2026 |
| Op Margin | 11% | n/a | Q2 2026 |
| Net Margin | 8.9% | n/a | Q2 2026 |
| ROE | 19% | n/a | Q2 2026 |
| ROA | 7.8% | n/a | Q2 2026 |
| ROIC | 16% | n/a | Q2 2026 |
| Free Cash Flow | $229M | +0.72% | Q2 2026 |
| P/E | 12.9 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Pediatrix Medical Group, Inc. (MD) - Revenue & ProfitRevenue & ProfitPediatrix Medical Group, Inc. (MD)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com